Laboratorio Pasteur S.A., commonly referred to as Pasteur, is a prominent player in the pharmaceutical and biotechnology industry, headquartered in Chile (CL). Established in 1992, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of vaccines and biopharmaceuticals. With a strong operational presence across Latin America, Laboratorio Pasteur S.A. is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of vaccines and therapeutic solutions, distinguished by their rigorous research and development processes. Pasteur's dedication to excellence has positioned it as a trusted name in the healthcare sector, achieving notable milestones in both product development and market expansion.
How does Laboratorio Pasteur S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Laboratorio Pasteur S.A.'s score of 25 is lower than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Laboratorio Pasteur S.A., headquartered in Chile (CL), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Laboratorios Sanfer, SA de CV, which may influence its climate commitments and performance metrics. Despite the lack of direct emissions data, Laboratorio Pasteur S.A. is part of a corporate family that may have established climate initiatives. However, no specific reduction targets or commitments have been documented for Laboratorio Pasteur S.A. itself, nor are there any climate pledges reported. As a subsidiary, it is essential to consider the broader context of its parent company, Laboratorios Sanfer, SA de CV, for insights into potential climate strategies and performance. The absence of specific data highlights the need for transparency and accountability in emissions reporting within the pharmaceutical industry, particularly as companies increasingly face pressure to disclose their environmental impact and set ambitious reduction targets.
Access structured emissions data, company-specific emission factors, and source documents
2022 | 2023 | |
---|---|---|
Scope 1 | 31,473,000,000 | 00,000,000,000 |
Scope 2 | 13,125,000,000 | 00,000,000,000 |
Scope 3 | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Laboratorio Pasteur S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.